D. H. Oh, D. J. Tybor, Tufts University School of Medicine, Boston, MA, USA A. G. Wurcel, D. Burke, Department of Geographic Medicine and Infectious Diseases, Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA, USA M. E. Menendez, M. J. Salzler, Department of Orthopaedics, Tufts Medical Center, Boston, MA, USA.
Clin Orthop Relat Res. 2018 Aug;476(8):1557-1565. doi: 10.1097/01.blo.0000534682.68856.d8.
The United States has a growing opioid epidemic impacting all aspects of health care including orthopaedic surgery. Septic arthritis of the knee is a condition commonly encountered by orthopaedic surgeons related to opioid and injection drug use (IDU). Changes in the frequency of hospitalizations for IDU-related septic arthritis and differences in septic arthritis patient outcomes according to IDU status in the setting of the burgeoning opioid epidemic are unknown.
QUESTIONS/PURPOSES: (1) What proportion of patients with septic arthritis of the knee use injection drugs? (2) Are there any differences in complications, reoperations, length of stay, and leaving against medical advice among patients with septic arthritis of the knee with and without IDU? (3) What are the age and racial trends in IDU-related septic arthritis of the knee from 2000 to 2013?
The Healthcare Cost and Utilization Project, Nationwide Inpatient Sample database of years 2000 to 2013 was utilized for patients between ages 15 and 64 years with a principal discharge diagnosis of native septic arthritis of the lower leg, the vast majority of which represents the knee. The Nationwide Inpatient Sample is the largest publicly available healthcare database in the United States that can show nationally representative clinical trends and outcomes. Septic arthritis was classified as related or unrelated to IDU based on previously published algorithms using billing codes. Patients with IDU-related septic arthritis were more likely to be black or Hispanic, younger, and use Medicare, Medicaid, or self-payment as their primary payment method. The yearly proportion of patients with septic arthritis who used injection drugs was determined. Hospitalization outcomes including length of stay, leaving against medical advice, number of procedures, and mortality rates were compared after adjusting for age, gender, and race in multivariable regression analyses. The yearly change in proportion of IDU-related septic arthritis in each age, race, and gender group was compared over the study period.
The proportion of patients with IDU-related septic arthritis increased from 5% in 2000 to 11% in 2013. After adjusting for age, gender, and race, patients with IDU-related septic arthritis were more likely to die during hospitalization (adjusted odds ratio [AOR], 2.86; 95% confidence interval [CI], 1.51-5.39; p < 0.001) and undergo repeat arthroscopic (AOR, 1.24; 95% CI, 1.06-1.45; p = 0.007) or open irrigation and débridement (AOR, 1.68; 95% CI, 1.28-2.19; p < 0.001). Patients with IDU-related septic arthritis were more likely to leave against medical advice (AOR, 7.13; 95% CI, 5.56-9.15; p < 0.001) and also had an additional 5 days in length of stay (95% CI, 4.1-5.5; p < 0.001) on average compared with patients with septic arthritis unrelated to IDU. There was an increasing proportion of patients with IDU-related septic arthritis who were aged 15 to 34 years and 55 to 64 years from 2000 to 2013.
IDU is increasingly the cause of septic knee admissions and is associated with higher rates of mortality, reoperations, resource utilization, and leaving against medical advice. Orthopaedic surgeons must adequately screen for IDU among patients with septic arthritis and monitor them closely for reoperation with a low threshold to reaspirate a knee in the postoperative period. Future studies should determine the current use and potential benefits of a multidisciplinary approach, including addiction specialists, to aid in the management of the increasing number of these patients.
Level III, therapeutic study.
美国阿片类药物泛滥,对包括骨科手术在内的各个方面的医疗保健都产生了影响。膝关节化脓性关节炎是骨科医生常见的疾病,与阿片类药物和注射药物的使用有关(IDU)。在阿片类药物泛滥的情况下,与 IDU 相关的膝关节化脓性关节炎的住院频率变化以及 IDU 状态对化脓性关节炎患者结局的影响尚不清楚。
问题/目的:(1)有多少膝关节化脓性关节炎患者使用注射药物?(2)有无 IDU 的膝关节化脓性关节炎患者在并发症、再次手术、住院时间和拒绝医疗建议方面是否存在差异?(3)2000 年至 2013 年,与 IDU 相关的膝关节化脓性关节炎的年龄和种族趋势是什么?
利用 2000 年至 2013 年期间的医疗保健成本和利用项目(Healthcare Cost and Utilization Project, Nationwide Inpatient Sample)数据库,对年龄在 15 至 64 岁之间的原发性下肢、绝大多数为膝关节的化脓性关节炎患者进行研究。Nationwide Inpatient Sample 是美国最大的公开医疗保健数据库,可显示全国代表性的临床趋势和结果。根据先前使用计费代码制定的算法,将化脓性关节炎分为与 IDU 相关或不相关。与 IDU 相关的化脓性关节炎患者更可能是黑人和西班牙裔,年龄更小,并且更可能使用医疗保险、医疗补助或自付作为主要支付方式。确定每年使用注射药物的化脓性关节炎患者比例。在多变量回归分析中,调整年龄、性别和种族后,比较住院结局,包括住院时间、拒绝医疗建议、手术次数和死亡率。比较研究期间每个年龄、种族和性别组中与 IDU 相关的化脓性关节炎比例的年变化。
与 IDU 相关的化脓性关节炎患者比例从 2000 年的 5%增加到 2013 年的 11%。在调整年龄、性别和种族后,与 IDU 相关的化脓性关节炎患者更有可能在住院期间死亡(调整后的优势比[OR],2.86;95%置信区间[CI],1.51-5.39;p < 0.001),并且更有可能接受重复关节镜(OR,1.24;95%CI,1.06-1.45;p = 0.007)或开放性灌洗和清创术(OR,1.68;95%CI,1.28-2.19;p < 0.001)。与 IDU 相关的化脓性关节炎患者更有可能拒绝医疗建议(OR,7.13;95%CI,5.56-9.15;p < 0.001),并且与与 IDU 无关的化脓性关节炎患者相比,平均住院时间延长了 5 天(95%CI,4.1-5.5;p < 0.001)。2000 年至 2013 年,与 IDU 相关的化脓性关节炎患者中,年龄在 15 至 34 岁和 55 至 64 岁的患者比例增加。
IDU 是导致膝关节化脓性关节炎入院的主要原因,与死亡率、再次手术、资源利用和拒绝医疗建议的发生率较高有关。骨科医生必须在化脓性关节炎患者中充分筛查 IDU,并密切监测他们的再次手术情况,以便在术后及时抽吸膝关节。未来的研究应确定当前多学科方法(包括成瘾专家)的使用情况和潜在益处,以帮助管理越来越多的此类患者。
三级,治疗性研究。